Publications
Meier-Ewert HK, Sanchorawala V, Berk JL, Ruberg FL. Cardiac Amyloidosis: Evolving Approach to Diagnosis and Management. Current Treatment Options Cardiovascular Medicine 2011; 13: 528-542.
Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica 2011 {Prepublished online on August 22, 2011}
Meier-Ewert HK, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Ruberg FL. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Amyloid 2011; 18 (1):125-126.
Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O’Connell R, O’Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid 2011;18 (1):122-124.
Reece D, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Blade J, Fermand J, Hassoun H, Heffner L, Vescio RA, Liu K, Enny C, Esseltine D, van de Velde H, Cakana A, ComenzoRL. Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL-amyloidosis: results of a phase-1/2 study. Blood 2011 {Prepublished online on May 11, 2011}
Sanchorawala V, Finn KT, Fennessey S, Shelton A, Doros G, Zeldis JB, Seldin DC.
Durable hematologic complete responses can be achieved with Lenalidomide in AL amyloidosis. Blood 2010; 116(11): 1990-1.
Currier, N., Chea K., Hlavacova, M., Sussman, D.J., Seldin, D.C. Dominguez, I., Dynamic expression of a LEF-EGFP Wnt reporter in mouse development and cancer. Genesis 2010 Mar; 48(3): 183-94.
Genetic Signatures of Exceptional Longevity in Humans Paola Sebastiani,1,* Nadia Solovieff,1 Annibale Puca,2 Stephen W. Hartley,1 Efthymia Melista,3 Stacy Andersen,4 Daniel A. Dworkis,3 Jemma B. Wilk,5 Richard H. Myers,5 Martin H. Steinberg,6 Monty Montano,3 Clinton T. Baldwin,6,7 Thomas T. Perls4,*
Tapan U, Seldin DC, Finn KT, Fennessey S, Shelton A, Zeldis JB, Sanchorawala V. Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis. Blood 2010; 116(23): 5071-2.
Sanchorawala V, Seldin DC, Berk JL, Sloan JM, Doros G, Skinner M. Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clinical Lymphoma, Myeloma & Leukemia 2010; 10(6): 469-472.